Sight Sciences (SGHT) Asset Writedowns and Impairment (2020 - 2026)
Sight Sciences' quarterly Asset Writedowns and Impairment came in at -$127000.0 in Q1 2026, down 462.86% year-on-year from $35000.0 in Q1 2025, and down 353.57% quarter-over-quarter from -$28000.0 in Q4 2025.
Sight Sciences has reported Asset Writedowns and Impairment for 7 years, with the latest figure at -$127000.0 in Q1 2026.
- For the quarter ending Q1 2026, Asset Writedowns and Impairment fell 462.86% year-over-year to -$127000.0; the trailing twelve-month figure through Mar 2026 stood at -$162000.0 (down 276.74% YoY), and the FY2024 full-year result was -$42000.0, down 121.21% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at -$127000.0, down from -$28000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $277000.0 in Q3 2022, with the low at -$127000.0 in Q2 2024.
- Average Asset Writedowns and Impairment over 5 years is $37823.5, with a median of $26000.0 recorded in 2024.
- Year-over-year, Asset Writedowns and Impairment surged 318.11% in 2022 and plunged 553.57% in 2024.
- Tracing SGHT's Asset Writedowns and Impairment over 5 years: stood at $219000.0 in 2022, then tumbled by 109.59% to -$21000.0 in 2023, then soared by 223.81% to $26000.0 in 2024, then sank by 207.69% to -$28000.0 in 2025, then tumbled by 353.57% to -$127000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at -$127000.0 (Q1 2026), -$28000.0 (Q4 2025), and -$33000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sight Sciences | 247.60 Mn | 162.64 Mn | 16.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -127,000.00 |
| Mar 31, 2026 | -127,000.00 |
| Dec 31, 2025 | -28,000.00 |
| Dec 31, 2025 | -28,000.00 |
| Sep 30, 2025 | -33,000.00 |
| Sep 30, 2025 | -33,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | -127,000.00 |
| Jun 30, 2024 | -127,000.00 |
| Mar 31, 2024 | 36,000.00 |
| Mar 31, 2024 | 36,000.00 |
| Dec 31, 2023 | -21,000.00 |
| Dec 31, 2023 | -21,000.00 |
| Sep 30, 2023 | 179,000.00 |
| Sep 30, 2023 | 179,000.00 |
| Jun 30, 2023 | 28,000.00 |
| Jun 30, 2023 | 28,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 219,000.00 |
| Dec 31, 2022 | 219,000.00 |
| Sep 30, 2022 | 277,000.00 |
| Sep 30, 2022 | 277,000.00 |
| Jun 30, 2022 | 110,000.00 |
| Jun 30, 2022 | 110,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 199,000.00 |
| Dec 31, 2021 | 199,000.00 |
| Sep 30, 2021 | -127,000.00 |
| Sep 30, 2021 | -127,000.00 |
| Jun 30, 2021 | 249,000.00 |
| Jun 30, 2021 | 249,000.00 |
| Mar 31, 2021 | 27,000.00 |
| Mar 31, 2021 | 27,000.00 |
| Dec 31, 2020 | 269,000.00 |
| Dec 31, 2020 | 269,000.00 |
| Sep 30, 2020 | 252,000.00 |
| Sep 30, 2020 | 252,000.00 |